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OBJECTIVES To determine the frequency of hospital admissions for acute coronary syndrome in young
adults and to examine the risk factors that predispose to the development of premature heart
disease.
BACKGROUND Significant coronary heart disease (CHD) is considered rare in the young adult. Current
guidelines do not recommend treatment of mild cholesterol abnormalities for primary
prevention of CHD in the young.
METHODS This is a large case series of 449 adults (#50 years) admitted to the hospital with acute
coronary syndrome. A history of cardiovascular risk factors and lipid profile were recorded.
The presence and extent of CHD were established.
RESULTS Mean patient age was 44 6 6 years. Documented CHD was present in 61% of hospital
admissions. Multivariate analysis revealed that history of hypercholesterolemia, history of
smoking and diabetes were independently associated with premature CHD. The fasting lipid
profiles were only borderline to mildly abnormal. Serum total cholesterol, low-density
lipoprotein (LDL) and triglyceride levels were not different in cases compared with control
subjects. Nearly half (49%) of those with LDL levels of $160 mg/dl had only one additional
risk factor or none. Despite this, a history of hypercholesterolemia had independent and
incremental value on other risk factors for the likelihood of premature CHD.
CONCLUSIONS The magnitude of hospital admissions relating to premature CHD is high. In this population,
the presence of borderline or mild hypercholesterolemia has significant effects on the
development of premature CHD. These observations have significant implications in the
development of guidelines for primary prevention of premature CHD. (J Am Coll Cardiol
2000;35:1178–84) © 2000 by the American College of Cardiology
The association between abnormal cholesterol metabolism
and coronary heart disease (CHD) is no longer in doubt.
Several epidemiologic studies have shown a direct, contin-
uous, graded and perhaps linear relationship between serum
cholesterol levels and cardiovascular events risk (1–4).
Additionally, randomized-control clinical trials have consis-
tently demonstrated that treatment of elevated cholesterol
levels is associated with significant reductions in recurrent
event rates in people with documented coronary disease. In
people without coronary disease, there is evidence that
certain high risk groups do benefit from treatment. How-
ever, confusion exists in the treatment of young men and
women with mild or moderate cholesterol abnormalities.
The National Cholesterol Education Program (NCEP) is
a national effort to increase both professional and public
awareness of the dangers of high cholesterol levels (4). The
NCEP has developed guidelines for both primary and
secondary prevention of coronary disease. The guidelines do
not recommend pharmacologic therapy for young adults
with moderate cholesterol elevations in the absence of
concomitant risk factors. Several reasons may be account-
able for the lack of endorsement of drug therapy. First, it is
generally believed that premature CHD is rare, and that the
absolute risk for a young adult with hypercholesterolemia
developing coronary disease is low (5). Second, the relation-
ship between cholesterol levels and CHD may be linear in
that the likelihood of cardiovascular events is relatively low
for people with mild and moderate cholesterol abnormalities
without multiple risk contributors (6). Third, there is
currently no evidence that treatment of mild cholesterol
abnormalities in the young is cost-effective. Fourth, the
long-term safety of the current medications remains un-
known.
However, the extent to which these assumptions remain
true for rural communities that may bear little or no
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resemblance to the study populations from which the
NCEP guidelines are based is unclear. We have noticed that
the frequency of hospital admission rates for young women
and men presenting with CHD in this community is high
(7,8).
We therefore undertook this study for the following
reasons: 1) to determine the frequency of patients with
symptomatic premature CHD presenting to our community
hospital in rural Wisconsin; 2) to determine the risk factor
profile and clinical characteristics of young men and women
presenting with acute coronary syndrome; and 3) to evaluate
the extent to which these young adults fit into the current
NCEP guidelines for primary prevention.
METHODS
Patient selection. This is an observational study that
constitutes 449 young men and women who were admitted
to the coronary care unit at the Gundersen Lutheran
Medical Center in La Crosse, Wisconsin with acute coro-
nary syndrome in a two-year period (November 1, 1995 to
October 31, 1997). This represents 22% of the total hospital
admissions (N 5 2,042) for acute coronary syndrome during
that period. Patients were included for age 50 years or
younger with an initial admitting diagnosis of acute coro-
nary syndrome. Patients were excluded for age .50 years or
if the initial or admitting diagnosis was noncardiac, even if
the final diagnosis was ischemic syndrome.
Data source and variables. Medical records of all eligible
patients were reviewed. Additional information was ob-
tained from existing databases. The databases consisted of
Summit (The Society of Thoracic Surgeons National Car-
diac Surgery DataBase, Summit Medical Systems, 1997),
the cardiac catheterization laboratory registry, the lipid and
diabetes clinics’ registry and a national myocardial infarction
(MI) registry (Genentech).
Patients were classified as having definite CHD on the
basis of acute MI, angiographic disease or coronary inter-
ventions, including surgical revascularization. Criteria for
MI included two of the following: angina, electrocardio-
graphic changes and elevated enzyme levels (creatine kinase,
creatine kinase myocardial band isoenzyme). Coronary an-
giography was considered abnormal for significant disease if
the luminal diameter of the stenotic segment was $70% by
visual inspection in two or more orthogonal views. The
presence of cardiovascular risk factors was noted. Body mass
index was calculated for all patients and expressed as weight
in kilograms divided by the square of height in meters
(kg/m2). Obesity was defined as body mass index $27.8 and
$27.3 for men and women, respectively. Hypertension was
defined as systolic blood pressure $140 mm Hg, diastolic
pressure of $90 mm Hg or current use of antihypertensive
medication. Cigarette smoking (yes or no) was ascertained
for current and previous use. History of smoking was
defined as total abstention for at least four weeks before
hospital admission. History of diabetes was considered
present if the individual was receiving therapy with either
insulin or an oral hypoglycemic agent. Additional criteria
included a fasting blood glucose level in excess of 150 mg/dl
on two occasions. Family history was defined as premature
CHD in first-degree relatives at age 55 years or younger and
65 or younger for men and women, respectively. Only lipid
profiles drawn within initial 48 h of hospital admission were
included. History of hypercholesterolemia was taken from
physician’s hospital admission notes. The final diagnoses
were confirmed by hospital discharge records.
The hospital has a defined catchment area and provides
services to patients living in 19 counties in western Wis-
consin, southeastern Minnesota and northeast Iowa. The
service area population is 530,697 persons. Approximately
78% of these individuals live in rural regions. The racial
make-up of the service area is 98% white, 1% Southeast
Asian and 1% Hispanic. The study population does not
differ from the population of this geographic area.
Statistical analysis. The data were analyzed with software
(SAS software Version 6.12; Cary, North Carolina: SAS
Institute; 1996). For the univariate analysis, the categorical
variables were compared using Fisher’s exact two-tailed test,
Pearson’s chi-square test or test for linear trend. The
continuous variables, which are expressed as mean 6 SD,
were compared by Student t test. For the multivariate
analysis, the following variables were tested for risk for
premature CHD using stepwise logistic regression: smok-
ing, diabetes, history of hyperlipidemia, obesity, family
history of premature coronary disease and hypertension.
This stepwise regression was set to enter variables into and
remove variables from the model in such a way that each
forward step is followed by a backward elimination. Vari-
ables must have met the p 5 0.05 criteria to be entered and
remain in the model. The odds ratio as an estimate of
multivariate relative risk (RR) and the 95% confidence
intervals before and after adjustment of confounding vari-
ables were calculated by logistic regression. The hypothesis
testing and the estimation of 95% confidence intervals were
performed using the standard error estimate for logistic
coefficient estimates.
RESULTS
General. There were 449 patients (only initial hospital
admission was counted in the case of multiple admissions)
of age 50 years or younger with acute coronary syndrome in
Abbreviations and Acronyms
CHD 5 coronary heart disease
HDL 5 high-density lipoprotein
LDL 5 low-density lipoprotein
MI 5 myocardial infarction
NCEP 5 National Cholesterol Education Program
RR 5 relative risk
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the two-year period. This represented 22% of all hospital
admissions (N 5 2,042) for acute coronary syndrome during
that period. The mean patient age was 44 6 6 years. There
were 132 (29.4%) women. Documented premature coronary
artery disease ($70% stenosis) was present in 61 (46%) and
212 (67%) women and men, respectively. The medications
at the time of hospital admission were as follows: beta-
adrenergic blocking agents (20.0%), calcium blockers
(13.5%), angiotensin-converting enzyme inhibitors (6.9%)
and alpha-blockers (1.6%). Thirty-five patients (7.8%) were
receiving statins, and an additional seven (1.6%) were
receiving either niacin or gemfibrozil. Table 1 presents a
more detailed description of the demographic profile.
Patients were categorized into group 1 if there was
irrefutable evidence of premature CHD (n 5 274; 61%).
Group 2 was comprised of the patients without definite
evidence of CHD. This included patients who were ruled
out for MI or who were classified as having low probability
for significant disease and therefore were not offered coro-
nary angiography, as well as patients with normal angio-
grams. The mean age for our population was 45 6 5 years
in group 1 and 43 6 6 years in group 2 (p 5 NS). Among
the women with premature coronary disease, 36% suffered
acute MI compared with 47% of the men (p , 0.14).
Angiographic disease. Among the 274 patients with pre-
mature CHD, left main involvement was present in 5%.
The distributions of coronary lesions in the remaining
patients were one vessel (27%), two vessels (28%) and three
vessels (22%). In another 15%, the extent of disease was
unknown. This included those with documented, uncom-
plicated MI who did not undergo diagnostic coronary
angiography, and those in whom the angiographic disease
was poorly documented. Insignificant coronary disease was
documented in 2% of patients. History of known cardio-
vascular disease was as follows: previous angiography (n 5
98), previous percutaneous transluminal coronary angio-
plasty (n 5 26), previous MI (n 5 54) and previous
coronary artery bypass graft (n 5 17).
Risk factors. Table 2 provides a summary of the details of
the risk factor distribution in the patients with and without
premature CHD (group 1 and group 2, respectively). The
risk factors examined were history of smoking, current
smoking, family history of premature CHD, obesity, dia-
betes mellitus and lipid profile. After adjusting for gender,
multivariate analysis revealed that history of hypercholester-
olemia (RR 3.0, p , 0.0001), history of smoking (RR 2.8,
p , 0.0001) and diabetes mellitus (RR 2.7, p , 0.007) were
independently associated with premature CHD. Among the
entire group, 186 patients (42%) gave history of having
hypercholesterolemia, and 168 (38%) admitted having hy-
pertension. As many as 315 (70%) and 231 (51%) had
history of smoking or were current smokers, respectively.
The occurrence rate for obesity as defined by body mass
index was 65%.
Group 1 patients had a significantly higher ratio of
history of hypercholesterolemia and smoking (both current
and history), as well as diabetes, than group 2 patients.
There was a trend for higher rates of hypertension (p 5
0.058) and family history of premature coronary disease
(p 5 0.053) in group 1 compared with group 2. The
Table 1. Patient Demographic Profile
Male Female
No. of Patients 317 (71%) 132 (29%)
% with CHD 67% 46%
Mean age (yr) 45 6 5.0 44 6 4.8
Hypertension 39% 35%
Hypercholesterolemia (Hx) 46% 35%
History of smoking 75% 59%
Obesity 67% 61%
Family history 42% 29%
Diabetes mellitus 12% 16%
*CHD 5 coronary heart disease; Hx 5 history.





% Without CHD p Value
Male gender 449 78% (213/274) 59% (104/175) 0.001
Hypercholesterolemia (Hx) 438 53% (144/274) 26% (42/164) 0.001
Hx of hypertension 440 42% (114/274) 33% (54/166) 0.058
Hx of smoking 449 80% (219/274) 55% (96/175) 0.001
Current smoker 449 58% (160/274) 41% (71/175) 0.001
Family Hx CHD 438 42% (114/274) 32% (53/164) 0.053
Obesity 438 66% (180/274) 65% (106/164) 0.822
Diabetes mellitus 436 16% (45/274) 8% (13/162) 0.013
LDL $160 mg/dl 233 29% (51/178) 25% (14/55) 0.644
Low HDL* 259 58% (115/199) 38% (23/60) 0.008
Total cholesterol $240 mg/dl 277 23% (48/207) 26% (18/70) 0.668
*Low HDL #35 mg/dl for men; #45 mg/dl for women.
CHD 5 coronary heart disease; HDL 5 high-density lipoprotein; Hx 5 history; LDL 5 low-density lipoprotein.
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frequencies of obesity in the two groups were similar (66%
vs. 65%).
Comparison with NCEP guidelines. There was a total of
277 patients who had total cholesterol level checked within
48 h of hospital admission. Of these, only 66 (23.8%)
patients had total cholesterol values of $240 mg/dl. A total
of 233 patients had an analysis of low-density lipoprotein
(LDL) cholesterol performed. Only 63 (27.2%) had fasting
LDL values of $160 mg/dl, and 123 (52.8%) had LDL
values of $130 mg/dl. Among those with a LDL choles-
terol level of $160 mg/dl, 8% had no identifiable risk factor
(n 5 5), 41% (n 5 26) had only one additional cardiovas-
cular risk, 31.7% (n 5 20) had two, 16% (n 5 10) had three
and 3.2% (n 5 2) had more than three additional risk
factors present (Fig. 1). In other words, as many as 49% of
subjects with LDL cholesterol levels $160 mg/dl had only
one or no recognized cardiovascular risk factor. Two hun-
dred fifty-nine patients had high-density lipoprotein
(HDL) cholesterol levels recorded, of whom 53% had low
HDL levels. The analysis was repeated counting low HDL
levels (#35 mg/dl for men and #45 mg/dl for women).
With HDL levels considered, 6.3% and 28.6% had either
none or only one additional risk factor, respectively. How-
ever, the number of risk factors present was associated with
severity of disease (F 5 19.9, p 5 0.000). Patients with
one-vessel disease had significantly more risk factors than
those without disease and significantly less risk factors than
those with three diseased vessels. The mean total cholesterol
level was not different among the group without CHD
compared to those with documented disease (201 6 52.4 vs.
207 6 51 mg/dl, p 5 0.4). Similarly, LDL cholesterol and
triglyceride levels were not different for the two groups
(128 6 38 vs. 135 6 40 mg/dl, p 5 0.3 and 201 6 171 vs.
225 6 158, p 5 0.3, respectively). Conversely, the group
with CHD had significantly lower HDL cholesterol levels
(37.7 6 10.5) compared to those without disease (44.3 6
10.0, p , 0.0001).
Influence of cholesterol and other risk factors. We ana-
lyzed the lipoprotein profile according to smoking status.
The mean total cholesterol level among nonsmokers was
significantly lower compared with the mean total cholesterol
level of smokers (192 6 49 vs. 211 6 51 mg/dl, p , 0.005).
Similarly, LDL cholesterol level was significantly lower
among nonsmokers (122 6 35 vs. 139 6 41 mg/dl, p ,
0.003). There was no difference in the mean HDL or
triglyceride levels in smokers compared with levels in
nonsmokers. History of hypercholesterolemia and smoking
were independent predictors of disease and their presence
together increased the probability of disease significantly.
The results of the stepwise logistic regression model are
illustrated in Table 3. The risk ratio for premature CHD is
3.0 for a patient with history of hypercholesterolemia (p ,
0.0001). The logistic regression model was repeated with all
variables simultaneously forced into the analysis. The results
showed that family history (p 5 0.7) and hypertension (p 5
0.2) were not statistically significant in predicting disease.
Obesity showed a trend toward significance (p 5 0.055),
although the odds ratio was less than one.
DISCUSSION
The main findings of our study are three-fold. First, the
study shows that contrary to current beliefs, a high propor-
tion (22%) of hospital admissions for acute coronary syn-
drome occur in young adults and as many as 61% have
significant angiographic disease. Second, the proportion of
patients with multivessel disease may suggest that the onset
of coronary disease in this population is early or that the
disease progression is rapid. Third, a significant number of
people do not get lipoprotein analysis, suggesting missed
opportunities for prevention of coronary disease.
A report issued by the National Heart, Lung and Blood
Institute Task Force on Research in Epidemiology and
Prevention of Cardiovascular Diseases in 1994 noted that
CHD death rates vary among geographic regions in the
U.S. (9). Studies done over the past five decades show that
cardiovascular disease mortality rates are highest in the
southeastern, northeastern and Appalachian states and low-
est in the Rocky Mountain and western states (10,11). Our
understanding of the contribution of modifiable, environ-
mental risk factors to the development of CHD has im-
proved. It is also true that the extent and distribution of each
known cardiovascular risk factor is dynamic within any
community and this may account, at least in part, for the
decreasing age-adjusted mortality rates for CHD (12–14).
Figure 1. Distribution of risk factors among patients with
LDL .160 mg/dl (see text for discussion). LDL 5 low-density
lipoprotein.






Smoking history 1.02 0.0001 2.8
Diabetes mellitus 0.99 0.007 2.7
Male gender 0.72 0.002 2.1
Hypercholesterolemia (Hx) 1.08 0.0001 2.96
Hx 5 history.
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The differential effect of each risk factor on the onset of
disease and prevalence rates, however, is yet to be docu-
mented. Based on currently available epidemiologic studies
it is generally believed that development of significant CHD
is rare in the young (5,15–17). This is believed to be
particularly true in the absence of diabetes (18), cocaine
abuse (19) or severely abnormal serum cholesterol levels
with multiple risk factors (20–24). The question then is why
so many young men and women in this geographic area
present with premature CHD. In just a two-year period, a
total of 449 patients 50 years or younger (22% of all hospital
admissions for acute coronary syndrome) were admitted to
the hospital with acute coronary syndrome, of whom 61%
had documented significant coronary artery disease. One
may ask if this is a local phenomenon limited to our
geographic catchment area. After all, the population here is
homogenous and stable with common ancestry from north-
ern Europe. It is possible that the population may carry a
genetic susceptibility for premature CHD. Furthermore,
smoking is habitual among the youth and obesity is a
prevalent problem in this area. Nevertheless, we believe that
it is entirely possible that the findings of this study are
representative of many other similar communities.
First, our current understanding of the epidemiology of
CHD is derived from studies that have been done from a
few select communities that are defined by proximity to
large educational and urban centers (25–28). In reality,
although many people live in rural settings, very few studies
have been done in these areas. In addition, recent studies
portray particularly troubling trends in the health profile of
U.S. adolescents such as increasing rates of cigarette smok-
ing (29), obesity (30) and physical inactivity (31). Moreover,
a recent autopsy report from the Bogalusa study showed that
even in children and young adults who died from noncardiac
causes, there was atherosclerotic disease in the aorta and
coronary arteries. The degree of atherosclerotic involvement
was correlated with the presence and number of traditional
coronary risk factors (32). The Bogalusa study is consistent
with previous reports involving young soldiers who died in
both the Korean (33) and Vietnam (34) conflicts as well as
the Pathobiological Determinants of Atherosclerosis in
Youth (PDAY) Study (35). We postulate that this is true for
most U.S. communities and that progression to clinically
significant disease in the young adult is variable and depen-
dent on the presence and extent (duration and severity) of
atherogenic risk factors such as smoking and obesity. This
may partly explain why as many as 55% of the patients had
multivessel disease, whereas other studies show that young
adults with premature CHD usually have single-vessel
disease with discrete lesions (36).
One interesting finding from the current study concerns
the lipid analysis and the risk factor profile of the patients.
The best way to deal with premature coronary disease is
prevention. For this reason, we asked how well could these
patients be identified prior to the events. Could these events
be prevented by current guidelines? Current guidelines on
hypercholesterolemia are not as clear or assertive on primary
prevention compared with secondary prevention. The
American College of Physicians does not recommend cho-
lesterol screening for young men (,35 years) or women
(,45 years) unless history and physical examination suggest
a familial lipoprotein disorder or at least two other charac-
teristics that increase the risk for CHD. Screening for
primary prevention is considered appropriate but not man-
datory for men 35 to 65 years of age and for women 45 to
65 years of age (37). If one considers that 22% of all our
hospital admissions for acute coronary syndrome occurred in
this group of patients 50 years or younger, clearly this
strategy would not have helped these patients. The NCEP
guidelines recommend fasting lipoprotein analysis only
when total cholesterol level is elevated to $240 mg/dl.
Therapy is not recommended for primary prevention unless
the LDL cholesterol level is $160 mg/dl and there are
concomitant risk factors (4). In our group of patients, only
24% had total cholesterol values of $240 mg/dl, and only
27% had fasting LDL values of $160 mg/dl. Among those
with LDL values of $160 mg/dl, approximately 49% had
either none or only one additional risk factor. Although the
values for total cholesterol, LDL and HDL cholesterol and
triglycerides were only borderline or mildly abnormal, his-
tory of hypercholesterolemia carried a significant indepen-
dent and incremental risk by multivariate analysis.
What then should be the target lipid profile for primary
prevention in this area? We believe the best strategy for
primary prevention should be aggressive reduction of all
modifiable risk factors. The rate of smoking in our patients
and indeed this community is unacceptably high. The extent
of obesity should be reduced and physical activity encour-
aged. What level of cholesterol abnormalities to treat cannot
be answered in this study, but the issue of cost-effectiveness
of treating mild hypercholesterolemia may need to be
revisited for few reasons. Current assumptions are based on
the belief that absolute risk for development of premature
CHD is low. This may not be true for this area and it is
possible that there are several other rural communities that
have similarly high rates that remain unrecognized. Second,
the lipoprotein analysis in our group suggests that most
patients may benefit from strategies that improve HDL
values. Furthermore, in a population with high rates of
premature CHD, preventing symptomatic CHD may be
cheaper in the long run because it is expensive to treat MI.
Once MI develops, the combined cost of secondary preven-
tive measures, coronary angiography, revascularization and
eventual development of ischemic cardiomyopathy becomes
extremely expensive. We reiterate the observation by Brown
and Goldstein (38) that total cholesterol of 200 mg/dl is
much too high. We agree with their suggestion that the
total cholesterol level in the population needs to be much
lower than the NCEP recommended criteria (38).
Study limitations. The current study is observational and
deserves necessary caution in the interpretation of the
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results. Patients admitted to our hospital are unselected and
reflect our community. However, the findings may not be
generalized to other communities where the population
differs from ours. We believe there are several other rural
communities that may share similarly high rates of prema-
ture CHD. In this regard, we believe the findings of this
study are important. Another limitation of our method is
that it does not allow us to derive incidence and prevalence
values by which we could compare with national data. We
recognize this weakness, but in reality the essential finding
of unacceptably high hospital admission rates for young
adults here calls for reevaluation of the extent of premature
CHD and current preventive strategies. Unfortunately, lipid
profile was not available for all patients, which is problem-
atic in using a retrospective design. Although we catego-
rized our patients into two groups based on irrefutable
evidence of coronary disease, in reality the groups may not
be different. It can be argued that they all have clinical
manifestations of disease (acute ischemic syndromes for
which they were admitted to the hospital). A control group
composed of patients without chest pain would be prefera-
ble. Viewed from this perspective, the findings of this study
become even more impressive, since one would expect the
differences between groups to be magnified if such a control
group was used.
CONCLUSIONS
We present our experience showing high hospital admission
rates for patients with premature CHD. Our study offers
new clinical and scientific information in cardiovascular
medicine, which includes the following. Many young adults
presenting with clinical evidence of premature CHD are not
adequately evaluated for prevention. A large number of
these patients have borderline or only mildly abnormal lipid
profiles. Only a few have multiple risk factors, yet many do
have multivessel disease. These findings suggest that in a
high risk population with high rates of smoking and obesity,
the incremental impact of borderline to mild cholesterol
abnormalities is significant. Furthermore, the high percent-
age of multivessel involvement does argue for early disease
onset or rapid progression and that prevention should be
started early and the criteria for therapy need review. This
suggests a need for protocols to reflect all modifiable risk
factors, including smoking, obesity, hypertension and hy-
percholesterolemia.
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